A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/167 (2006.01) A61K 31/475 (2006.01) A61K 31/704 (2006.01) A61P 35/00 (2006.01) C07C 237/04 (2006.01)
Patent
CA 2673449
An antitumor combination comprising a stilbene derivative and an anticancer compound selected from the group consisting of taxanes, alkylating agents, antimetabolites, vinca alkaloids, epidophylloptoxins, and antibiotics as the active ingredients is provided. There are also provided methods of using these pharmaceutical preparations for the treatment of solid carcinomas and the like.
Une composition antitumorale est divulguée, qui comprend un dérivé du stilbène et un composé anticancéreux choisi dans le groupe constitué de taxanes, d'agents alkylants, d'antimétabolites, d'alcaloïdes Vinca, d'épidophylloptoxines et d'antibiotiques comme ingrédients actifs. Sont également décrites des méthodes d'utilisation de ces préparations thérapeutiques pour le traitement de carcinomes solides et de pathologies apparentées.
Aventis Pharma S.a.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
A combination comprising combretastatin and anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A combination comprising combretastatin and anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A combination comprising combretastatin and anticancer agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952705